HASAN, K. M.; ELMESHHADANY, A. Y.; SHABILA, N. P. Evaluation of Ruxolitinib versus Best Available Therapy in Treating Primary Myelofibrosis. Sultan Qaboos University Medical Journal, [S. l.], v. 22, n. 3, p. 393–399, 2022. DOI: 10.18295/squmj.8.2021.110. Disponível em: https://journals.squ.edu.om/index.php/squmj/article/view/4522. Acesso em: 20 apr. 2024.